| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macular Degeneration | 13 | 2021 | 75 | 4.570 |
Why?
|
| Retinal Pigment Epithelium | 17 | 2021 | 145 | 3.990 |
Why?
|
| Retinal Degeneration | 17 | 2011 | 75 | 3.720 |
Why?
|
| Choroidal Neovascularization | 9 | 2018 | 35 | 3.490 |
Why?
|
| Photoreceptor Cells, Vertebrate | 12 | 2021 | 46 | 2.980 |
Why?
|
| Complement Pathway, Alternative | 9 | 2016 | 69 | 2.980 |
Why?
|
| Retina | 20 | 2020 | 252 | 2.790 |
Why?
|
| Oxidative Stress | 14 | 2016 | 718 | 2.640 |
Why?
|
| Complement Activation | 11 | 2021 | 145 | 2.390 |
Why?
|
| Complement System Proteins | 10 | 2020 | 135 | 2.310 |
Why?
|
| Smoke | 4 | 2021 | 46 | 2.160 |
Why?
|
| Retinal Cone Photoreceptor Cells | 8 | 2012 | 74 | 1.920 |
Why?
|
| Retinal Rod Photoreceptor Cells | 10 | 2021 | 71 | 1.900 |
Why?
|
| Mice | 61 | 2021 | 8474 | 1.830 |
Why?
|
| Disease Models, Animal | 21 | 2021 | 2550 | 1.560 |
Why?
|
| Gene Expression Regulation | 12 | 2021 | 1293 | 1.500 |
Why?
|
| Eye Proteins | 14 | 2010 | 160 | 1.500 |
Why?
|
| Retinitis Pigmentosa | 3 | 2021 | 17 | 1.480 |
Why?
|
| Electroretinography | 19 | 2016 | 122 | 1.450 |
Why?
|
| Mice, Inbred C57BL | 31 | 2021 | 2791 | 1.440 |
Why?
|
| Animals | 70 | 2021 | 20881 | 1.390 |
Why?
|
| Mitochondria | 6 | 2021 | 643 | 1.320 |
Why?
|
| Choroid | 4 | 2018 | 22 | 1.270 |
Why?
|
| Complement Membrane Attack Complex | 3 | 2014 | 20 | 1.250 |
Why?
|
| Retinaldehyde | 11 | 2013 | 115 | 1.180 |
Why?
|
| Organ Culture Techniques | 5 | 2021 | 122 | 1.150 |
Why?
|
| Complement C5a | 2 | 2018 | 15 | 1.150 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2016 | 376 | 1.140 |
Why?
|
| Rod Opsins | 8 | 2008 | 59 | 1.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2012 | 219 | 1.050 |
Why?
|
| Lasers | 4 | 2015 | 61 | 1.010 |
Why?
|
| Radiation Injuries, Experimental | 3 | 2011 | 22 | 0.970 |
Why?
|
| Mice, Knockout | 27 | 2018 | 1692 | 0.950 |
Why?
|
| RNA, Messenger | 9 | 2015 | 1664 | 0.930 |
Why?
|
| cis-trans-Isomerases | 13 | 2013 | 63 | 0.920 |
Why?
|
| Apoptosis | 8 | 2011 | 1641 | 0.900 |
Why?
|
| Neuroprotective Agents | 3 | 2021 | 317 | 0.890 |
Why?
|
| Aging | 7 | 2018 | 911 | 0.870 |
Why?
|
| Carrier Proteins | 12 | 2010 | 597 | 0.830 |
Why?
|
| Cell Line | 12 | 2021 | 1752 | 0.810 |
Why?
|
| Light | 6 | 2011 | 152 | 0.800 |
Why?
|
| Complement C3 | 3 | 2018 | 101 | 0.770 |
Why?
|
| Autophagy | 5 | 2016 | 208 | 0.750 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2018 | 20 | 0.750 |
Why?
|
| Receptors, IgG | 1 | 2021 | 94 | 0.730 |
Why?
|
| Elastin | 1 | 2021 | 116 | 0.730 |
Why?
|
| Photoreceptor Cells | 5 | 2007 | 62 | 0.710 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 116 | 0.700 |
Why?
|
| Calpain | 4 | 2016 | 205 | 0.700 |
Why?
|
| Cigarette Smoking | 1 | 2021 | 104 | 0.690 |
Why?
|
| Immunotherapy | 1 | 2021 | 215 | 0.680 |
Why?
|
| Receptor, trkB | 3 | 2004 | 27 | 0.650 |
Why?
|
| Cell Survival | 8 | 2021 | 901 | 0.650 |
Why?
|
| Proteins | 6 | 2007 | 474 | 0.640 |
Why?
|
| Th17 Cells | 2 | 2017 | 116 | 0.630 |
Why?
|
| Peptides | 1 | 2021 | 455 | 0.630 |
Why?
|
| Recovery of Function | 2 | 2016 | 506 | 0.620 |
Why?
|
| Gene Expression Profiling | 6 | 2010 | 498 | 0.620 |
Why?
|
| Complement Factor B | 2 | 2015 | 19 | 0.620 |
Why?
|
| Calcium | 4 | 2012 | 929 | 0.590 |
Why?
|
| Stress, Physiological | 2 | 2016 | 215 | 0.580 |
Why?
|
| Blotting, Western | 7 | 2021 | 954 | 0.570 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2016 | 8 | 0.550 |
Why?
|
| RNA | 2 | 2014 | 171 | 0.540 |
Why?
|
| src-Family Kinases | 2 | 2014 | 91 | 0.540 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2014 | 710 | 0.530 |
Why?
|
| Protective Agents | 1 | 2016 | 36 | 0.520 |
Why?
|
| Oxygen Consumption | 2 | 2016 | 258 | 0.510 |
Why?
|
| Complement C1q | 2 | 2013 | 18 | 0.510 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 53 | 0.510 |
Why?
|
| Vision, Ocular | 6 | 2010 | 68 | 0.500 |
Why?
|
| Complement Inactivating Agents | 3 | 2020 | 56 | 0.500 |
Why?
|
| Cells, Cultured | 8 | 2021 | 2673 | 0.490 |
Why?
|
| Complement Factor H | 2 | 2012 | 21 | 0.480 |
Why?
|
| Mice, Inbred BALB C | 8 | 2011 | 532 | 0.480 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 93 | 0.480 |
Why?
|
| Energy Metabolism | 1 | 2016 | 222 | 0.460 |
Why?
|
| Chemokines | 1 | 2014 | 119 | 0.460 |
Why?
|
| CD59 Antigens | 1 | 2014 | 30 | 0.460 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 266 | 0.460 |
Why?
|
| Oxidants | 4 | 2016 | 48 | 0.460 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 99 | 0.450 |
Why?
|
| Cone Opsins | 1 | 2013 | 9 | 0.440 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 1 | 2013 | 4 | 0.440 |
Why?
|
| Eye Diseases | 1 | 2013 | 38 | 0.440 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2016 | 209 | 0.440 |
Why?
|
| Cell Death | 4 | 2016 | 329 | 0.440 |
Why?
|
| Lipids | 2 | 2014 | 298 | 0.430 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 159 | 0.430 |
Why?
|
| Phospholipids | 1 | 2013 | 108 | 0.430 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 333 | 0.420 |
Why?
|
| Substantia Nigra | 4 | 2010 | 102 | 0.420 |
Why?
|
| Retinal Neovascularization | 1 | 2012 | 7 | 0.410 |
Why?
|
| Immunoglobulin M | 1 | 2013 | 172 | 0.410 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2010 | 124 | 0.410 |
Why?
|
| Microscopy, Electron | 3 | 2021 | 351 | 0.400 |
Why?
|
| Receptors, Complement 3d | 1 | 2012 | 45 | 0.400 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 64 | 0.390 |
Why?
|
| Morphogenesis | 1 | 2012 | 159 | 0.390 |
Why?
|
| Models, Biological | 2 | 2013 | 981 | 0.390 |
Why?
|
| Signal Transduction | 3 | 2013 | 2689 | 0.390 |
Why?
|
| Hydrogen Peroxide | 4 | 2016 | 168 | 0.390 |
Why?
|
| Glycolysis | 3 | 2016 | 79 | 0.360 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 223 | 0.360 |
Why?
|
| Sirolimus | 1 | 2011 | 118 | 0.360 |
Why?
|
| Rhodopsin | 7 | 2013 | 135 | 0.350 |
Why?
|
| Cyclic GMP | 2 | 2007 | 99 | 0.340 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2009 | 19 | 0.330 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 514 | 0.290 |
Why?
|
| Humans | 25 | 2020 | 68618 | 0.280 |
Why?
|
| Phenotype | 3 | 2014 | 947 | 0.280 |
Why?
|
| Caspase 3 | 4 | 2011 | 233 | 0.280 |
Why?
|
| Complement Pathway, Classical | 1 | 2006 | 22 | 0.280 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 507 | 0.280 |
Why?
|
| Nerve Degeneration | 3 | 2008 | 134 | 0.270 |
Why?
|
| Mice, Transgenic | 6 | 2015 | 1033 | 0.270 |
Why?
|
| Mice, Mutant Strains | 3 | 2016 | 166 | 0.270 |
Why?
|
| Periodicity | 1 | 2006 | 43 | 0.260 |
Why?
|
| Xenopus laevis | 1 | 2006 | 60 | 0.260 |
Why?
|
| Smoking | 1 | 2014 | 1452 | 0.260 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 4 | 2010 | 52 | 0.250 |
Why?
|
| Gene Silencing | 1 | 2006 | 137 | 0.250 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 499 | 0.250 |
Why?
|
| Receptor, trkA | 1 | 2004 | 13 | 0.250 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 173 | 0.250 |
Why?
|
| Genetic Vectors | 1 | 2006 | 312 | 0.250 |
Why?
|
| RNA Interference | 1 | 2006 | 266 | 0.250 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2011 | 160 | 0.240 |
Why?
|
| Photic Stimulation | 5 | 2016 | 229 | 0.240 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 4 | 2009 | 95 | 0.240 |
Why?
|
| Calcium Channels, L-Type | 2 | 2014 | 34 | 0.240 |
Why?
|
| Optic Neuritis | 2 | 2016 | 26 | 0.230 |
Why?
|
| Primary Cell Culture | 2 | 2016 | 56 | 0.230 |
Why?
|
| Caspases | 1 | 2004 | 194 | 0.230 |
Why?
|
| Interneurons | 1 | 2004 | 70 | 0.230 |
Why?
|
| Organ Specificity | 3 | 2016 | 167 | 0.230 |
Why?
|
| Retinal Ganglion Cells | 2 | 2016 | 72 | 0.220 |
Why?
|
| Tyrosine 3-Monooxygenase | 4 | 2010 | 71 | 0.220 |
Why?
|
| Dopamine | 4 | 2010 | 474 | 0.210 |
Why?
|
| Cytokines | 3 | 2018 | 866 | 0.210 |
Why?
|
| Rod Cell Outer Segment | 1 | 2003 | 56 | 0.210 |
Why?
|
| Tobacco | 2 | 2014 | 161 | 0.210 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 1174 | 0.210 |
Why?
|
| Synapses | 1 | 2004 | 222 | 0.200 |
Why?
|
| Lipoproteins | 1 | 2003 | 161 | 0.200 |
Why?
|
| Gene Dosage | 1 | 2001 | 47 | 0.200 |
Why?
|
| Up-Regulation | 3 | 2009 | 682 | 0.200 |
Why?
|
| Protein Transport | 3 | 2013 | 280 | 0.200 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2021 | 19 | 0.190 |
Why?
|
| Glutamic Acid | 1 | 2004 | 332 | 0.190 |
Why?
|
| Mitochondrial Diseases | 1 | 2021 | 24 | 0.190 |
Why?
|
| Neurons | 3 | 2010 | 881 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 290 | 0.190 |
Why?
|
| Male | 14 | 2016 | 37321 | 0.190 |
Why?
|
| Gene Expression | 3 | 2016 | 770 | 0.190 |
Why?
|
| Inflammation | 2 | 2018 | 1030 | 0.180 |
Why?
|
| Retinal Diseases | 1 | 2020 | 40 | 0.180 |
Why?
|
| Computational Biology | 2 | 2012 | 190 | 0.180 |
Why?
|
| Calcium Signaling | 2 | 2014 | 97 | 0.170 |
Why?
|
| Ultraviolet Rays | 2 | 2013 | 130 | 0.170 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 142 | 0.170 |
Why?
|
| Microglia | 1 | 2020 | 143 | 0.170 |
Why?
|
| DNA | 2 | 2016 | 597 | 0.170 |
Why?
|
| Peroxidases | 1 | 2018 | 28 | 0.160 |
Why?
|
| Retinoids | 2 | 2018 | 122 | 0.160 |
Why?
|
| Visual Acuity | 2 | 2016 | 236 | 0.160 |
Why?
|
| Time Factors | 5 | 2013 | 4655 | 0.150 |
Why?
|
| Bruch Membrane | 1 | 2018 | 6 | 0.150 |
Why?
|
| Cell Movement | 2 | 2016 | 630 | 0.150 |
Why?
|
| Enzyme Activation | 2 | 2014 | 791 | 0.150 |
Why?
|
| Calcium Channels | 2 | 2011 | 59 | 0.150 |
Why?
|
| Dipeptides | 2 | 2011 | 89 | 0.150 |
Why?
|
| Inflammasomes | 1 | 2018 | 39 | 0.150 |
Why?
|
| Glutathione Peroxidase | 2 | 2007 | 39 | 0.150 |
Why?
|
| Spleen | 2 | 2016 | 301 | 0.140 |
Why?
|
| Mesothelioma | 1 | 2017 | 21 | 0.140 |
Why?
|
| Corpus Striatum | 3 | 2010 | 279 | 0.140 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 742 | 0.140 |
Why?
|
| Forecasting | 1 | 2018 | 277 | 0.140 |
Why?
|
| Carbamates | 1 | 2016 | 41 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2007 | 114 | 0.140 |
Why?
|
| Light Coagulation | 1 | 2016 | 4 | 0.140 |
Why?
|
| Melanoma, Experimental | 1 | 2017 | 95 | 0.130 |
Why?
|
| Cellular Senescence | 1 | 2017 | 112 | 0.130 |
Why?
|
| Proton Ionophores | 1 | 2016 | 7 | 0.130 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2016 | 14 | 0.130 |
Why?
|
| Antibodies, Neutralizing | 1 | 2016 | 46 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 37 | 0.130 |
Why?
|
| Fibrosis | 1 | 2018 | 371 | 0.130 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2017 | 132 | 0.130 |
Why?
|
| Superoxides | 1 | 2016 | 70 | 0.130 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 215 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2016 | 62 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 3 | 2004 | 196 | 0.130 |
Why?
|
| Biological Assay | 1 | 2016 | 88 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2016 | 156 | 0.130 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2014 | 14 | 0.120 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2014 | 11 | 0.120 |
Why?
|
| Nerve Growth Factors | 2 | 2007 | 75 | 0.120 |
Why?
|
| Electron Transport | 1 | 2014 | 37 | 0.120 |
Why?
|
| Cell Respiration | 1 | 2014 | 47 | 0.120 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 72 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2018 | 384 | 0.120 |
Why?
|
| Pigment Epithelium of Eye | 3 | 2010 | 28 | 0.120 |
Why?
|
| Tomography, Optical Coherence | 1 | 2015 | 88 | 0.120 |
Why?
|
| Injections, Intraperitoneal | 2 | 2011 | 89 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2010 | 1200 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 1851 | 0.120 |
Why?
|
| Transcription Factor CHOP | 1 | 2014 | 28 | 0.120 |
Why?
|
| Motor Activity | 4 | 2011 | 621 | 0.120 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 69 | 0.120 |
Why?
|
| Female | 9 | 2014 | 38074 | 0.120 |
Why?
|
| Animals, Genetically Modified | 2 | 2021 | 63 | 0.110 |
Why?
|
| Receptors, Complement | 1 | 2014 | 58 | 0.110 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 62 | 0.110 |
Why?
|
| Arginine | 1 | 2014 | 102 | 0.110 |
Why?
|
| Regeneration | 2 | 2006 | 105 | 0.110 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 112 | 0.110 |
Why?
|
| Action Potentials | 1 | 2014 | 223 | 0.110 |
Why?
|
| Mice, Inbred ICR | 2 | 2004 | 44 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 659 | 0.110 |
Why?
|
| Lectins | 1 | 2013 | 81 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 61 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2016 | 431 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2014 | 525 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 186 | 0.110 |
Why?
|
| Molecular Weight | 1 | 2013 | 358 | 0.110 |
Why?
|
| Tretinoin | 1 | 2013 | 92 | 0.110 |
Why?
|
| Opsins | 2 | 2010 | 19 | 0.110 |
Why?
|
| Transducin | 2 | 2010 | 31 | 0.100 |
Why?
|
| Biomarkers | 2 | 2012 | 1593 | 0.100 |
Why?
|
| Vitamin A | 1 | 2013 | 111 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 94 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 157 | 0.100 |
Why?
|
| Genetic Therapy | 1 | 2014 | 291 | 0.100 |
Why?
|
| Mass Spectrometry | 2 | 2003 | 284 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2012 | 87 | 0.100 |
Why?
|
| Tristetraprolin | 1 | 2011 | 9 | 0.100 |
Why?
|
| Blindness | 2 | 2008 | 22 | 0.100 |
Why?
|
| Fetus | 1 | 2012 | 157 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 314 | 0.100 |
Why?
|
| Acyltransferases | 2 | 2008 | 40 | 0.100 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 15 | 0.090 |
Why?
|
| Demyelinating Diseases | 1 | 2011 | 57 | 0.090 |
Why?
|
| Amidohydrolases | 1 | 2011 | 60 | 0.090 |
Why?
|
| Central Nervous System Diseases | 1 | 2011 | 40 | 0.090 |
Why?
|
| Plasmids | 1 | 2012 | 258 | 0.090 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2011 | 73 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 82 | 0.090 |
Why?
|
| Acetylcysteine | 1 | 2014 | 296 | 0.090 |
Why?
|
| Ligands | 1 | 2012 | 317 | 0.090 |
Why?
|
| Nicotine | 1 | 2014 | 350 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2010 | 381 | 0.090 |
Why?
|
| Light Signal Transduction | 1 | 2010 | 6 | 0.090 |
Why?
|
| Genes | 1 | 2010 | 86 | 0.090 |
Why?
|
| ras Proteins | 1 | 2011 | 102 | 0.090 |
Why?
|
| G-Protein-Coupled Receptor Kinase 1 | 1 | 2010 | 6 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 102 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2008 | 447 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2010 | 154 | 0.080 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2009 | 10 | 0.080 |
Why?
|
| Cluster Analysis | 2 | 2012 | 219 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 320 | 0.080 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2008 | 7 | 0.080 |
Why?
|
| Phospholipases A2 | 1 | 2008 | 32 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 765 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 334 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 261 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1173 | 0.080 |
Why?
|
| Complement Factor D | 1 | 2007 | 3 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2012 | 753 | 0.080 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2007 | 5 | 0.070 |
Why?
|
| Uveitis | 1 | 2007 | 13 | 0.070 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2007 | 11 | 0.070 |
Why?
|
| Beclin-1 | 1 | 2007 | 11 | 0.070 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2007 | 24 | 0.070 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2007 | 18 | 0.070 |
Why?
|
| Docosahexaenoic Acids | 1 | 2007 | 12 | 0.070 |
Why?
|
| Caspase Inhibitors | 1 | 2007 | 36 | 0.070 |
Why?
|
| Adenine | 1 | 2007 | 46 | 0.070 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2007 | 28 | 0.070 |
Why?
|
| Protein Denaturation | 1 | 2007 | 27 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2007 | 75 | 0.070 |
Why?
|
| Nitric Oxide Donors | 1 | 2007 | 54 | 0.070 |
Why?
|
| Genes, RAG-1 | 1 | 2006 | 4 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 100 | 0.070 |
Why?
|
| Catalase | 1 | 2007 | 85 | 0.070 |
Why?
|
| DNA Primers | 1 | 2007 | 302 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2006 | 134 | 0.070 |
Why?
|
| Necrosis | 1 | 2007 | 239 | 0.070 |
Why?
|
| Caspase 1 | 1 | 2006 | 22 | 0.070 |
Why?
|
| Frontal Lobe | 2 | 2004 | 156 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2006 | 238 | 0.070 |
Why?
|
| S-Nitrosoglutathione | 1 | 2007 | 87 | 0.070 |
Why?
|
| Risk Factors | 2 | 2014 | 5731 | 0.070 |
Why?
|
| Muramidase | 1 | 2006 | 38 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2007 | 597 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2006 | 144 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2007 | 186 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 200 | 0.060 |
Why?
|
| Base Sequence | 1 | 2007 | 1015 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 434 | 0.060 |
Why?
|
| Biological Transport | 1 | 2005 | 210 | 0.060 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2004 | 40 | 0.060 |
Why?
|
| Homovanillic Acid | 1 | 2004 | 52 | 0.060 |
Why?
|
| Agmatine | 1 | 2004 | 1 | 0.060 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2004 | 31 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 337 | 0.060 |
Why?
|
| Caspase 10 | 1 | 2004 | 1 | 0.060 |
Why?
|
| Calcimycin | 1 | 2004 | 32 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 329 | 0.060 |
Why?
|
| Ionophores | 1 | 2004 | 25 | 0.060 |
Why?
|
| Ion Channel Gating | 1 | 2004 | 42 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 204 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 1083 | 0.060 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2004 | 75 | 0.060 |
Why?
|
| Neuroglia | 1 | 2004 | 136 | 0.060 |
Why?
|
| Transfection | 1 | 2006 | 782 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 328 | 0.060 |
Why?
|
| Aminobutyrates | 1 | 2004 | 94 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 615 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2008 | 617 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 1447 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2004 | 235 | 0.060 |
Why?
|
| Albinism | 1 | 2003 | 3 | 0.060 |
Why?
|
| Hippocalcin | 1 | 2003 | 1 | 0.050 |
Why?
|
| Recoverin | 1 | 2003 | 3 | 0.050 |
Why?
|
| Microspectrophotometry | 1 | 2003 | 9 | 0.050 |
Why?
|
| Calbindins | 1 | 2003 | 23 | 0.050 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2003 | 21 | 0.050 |
Why?
|
| Dark Adaptation | 1 | 2003 | 39 | 0.050 |
Why?
|
| Disease Progression | 1 | 2006 | 1038 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2004 | 236 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 92 | 0.050 |
Why?
|
| Injections | 1 | 2003 | 119 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 1047 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2003 | 114 | 0.050 |
Why?
|
| Locus Coeruleus | 1 | 2003 | 55 | 0.050 |
Why?
|
| Glutarates | 1 | 2002 | 6 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2003 | 276 | 0.050 |
Why?
|
| Triamcinolone Acetonide | 1 | 2002 | 10 | 0.050 |
Why?
|
| Mitomycin | 1 | 2002 | 27 | 0.050 |
Why?
|
| Aged | 2 | 2016 | 14862 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2003 | 396 | 0.050 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2021 | 1 | 0.050 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 7 | 0.050 |
Why?
|
| Databases, Genetic | 2 | 2012 | 52 | 0.050 |
Why?
|
| Diterpenes | 3 | 2006 | 42 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 137 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 284 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2020 | 65 | 0.050 |
Why?
|
| Zebrafish | 1 | 2021 | 187 | 0.040 |
Why?
|
| Heterozygote | 2 | 2010 | 174 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2003 | 1034 | 0.040 |
Why?
|
| Lipofuscin | 1 | 2018 | 43 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits | 2 | 2010 | 12 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2018 | 120 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1745 | 0.040 |
Why?
|
| Synaptosomes | 2 | 2010 | 57 | 0.040 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2016 | 5 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2017 | 75 | 0.030 |
Why?
|
| Gliosis | 1 | 2016 | 51 | 0.030 |
Why?
|
| Myelin Basic Protein | 1 | 2016 | 62 | 0.030 |
Why?
|
| Retinal Pigments | 2 | 2008 | 61 | 0.030 |
Why?
|
| Mutation | 1 | 2021 | 1213 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 133 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2016 | 118 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 170 | 0.030 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 17 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 201 | 0.030 |
Why?
|
| Rats | 3 | 2011 | 5300 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2014 | 56 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 2012 | 24 | 0.030 |
Why?
|
| Swine | 1 | 2014 | 672 | 0.030 |
Why?
|
| Genome, Human | 1 | 2012 | 62 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2012 | 63 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 706 | 0.030 |
Why?
|
| Genomics | 1 | 2012 | 168 | 0.020 |
Why?
|
| Rotarod Performance Test | 1 | 2011 | 3 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 173 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2011 | 24 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2011 | 150 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 2011 | 52 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 127 | 0.020 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2010 | 9 | 0.020 |
Why?
|
| Synaptic Vesicles | 1 | 2010 | 18 | 0.020 |
Why?
|
| Optic Nerve | 1 | 2011 | 55 | 0.020 |
Why?
|
| Maze Learning | 1 | 2011 | 138 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 139 | 0.020 |
Why?
|
| Neostriatum | 1 | 2010 | 60 | 0.020 |
Why?
|
| Electromyography | 1 | 2011 | 184 | 0.020 |
Why?
|
| Microdialysis | 1 | 2010 | 147 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2010 | 121 | 0.020 |
Why?
|
| Potassium | 1 | 2010 | 168 | 0.020 |
Why?
|
| Adaptation, Ocular | 1 | 2010 | 7 | 0.020 |
Why?
|
| Biophysics | 1 | 2010 | 41 | 0.020 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2010 | 82 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2011 | 111 | 0.020 |
Why?
|
| Postural Balance | 1 | 2010 | 93 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2011 | 244 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 658 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2012 | 310 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 448 | 0.020 |
Why?
|
| Netherlands | 1 | 2009 | 68 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2008 | 34 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 455 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 554 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2008 | 68 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2008 | 25 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2008 | 87 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 626 | 0.020 |
Why?
|
| Software | 1 | 2010 | 418 | 0.020 |
Why?
|
| Retinol-Binding Proteins | 1 | 2007 | 28 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 246 | 0.020 |
Why?
|
| Hair Color | 1 | 2006 | 4 | 0.020 |
Why?
|
| Pigmentation | 1 | 2006 | 12 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2008 | 248 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1196 | 0.020 |
Why?
|
| Isomerism | 1 | 2006 | 63 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2008 | 324 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 411 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 492 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1864 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2008 | 272 | 0.020 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 31 | 0.020 |
Why?
|
| Pregnancy | 1 | 2010 | 2334 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 16 | 0.020 |
Why?
|
| Cell Count | 1 | 2005 | 248 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2004 | 282 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 357 | 0.010 |
Why?
|
| Pigments, Biological | 1 | 2003 | 15 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 475 | 0.010 |
Why?
|
| Symporters | 1 | 2003 | 27 | 0.010 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2003 | 21 | 0.010 |
Why?
|
| Brain Stem | 1 | 2003 | 46 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2009 | 1451 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2003 | 155 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2003 | 173 | 0.010 |
Why?
|
| Cerebellum | 1 | 2003 | 103 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 124 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 144 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 371 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 541 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 2176 | 0.010 |
Why?
|
| Hippocampus | 1 | 2003 | 471 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7029 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 1070 | 0.010 |
Why?
|